Amikacin (Arikayce)

Status:
Red
Decision Date:
March 2021
 

Comments

RED: ES36: Nebulised liposomal amikacin for the treatment of non-tuberculous mycobacterial lung infections caused by Mycobacterium aviumcomplex in adults with limited treatment options who do not have cystic fibrosis. (Decision date - June 2021)

search again

Derby and Derbyshire CCG

Derby and Derbyshire CCG

Please click the button to navigate to our app

Redirect to app